The activation of Notch pathway induces the expression of IL-6 in malignant cells of different tumors, i.e., in colon cancer, stimulates tumor cell proliferation (60), and in luminal breast cancer, it promotes self-renewal and drug resistance (61). Here, IL6 is linked to breast carcinoma.